Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3193640 | Annals of Allergy, Asthma & Immunology | 2006 | 9 Pages |
Abstract
Diphenhydramine, 50 mg, given for 1 week provided statistically significant and clinically superior improvements in symptoms compared with 5 mg of desloratadine in patients with moderate-to-severe SAR. Somnolence occurred more frequently with diphenhydramine (22.1%) compared with desloratadine (4.5%) and placebo (3.4%).
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Gordon D. MD, James T. PharmD, Mei-Miau DrPH, Howard M. MD,